SEC Form D private-offering filing
Alto Neuroscience, Inc.
A new SEC Form D private-offering notice from Mountain View, CA, a $49,999,533 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage biopharmaceutical company developing precision medicines for psychiatric disorders such as depression and schizophrenia using an EEG and biomarker driven platform
Filed 2025-10-27Filed to raise $49,999,533First money in 2025-10-21Raised so far $49,999,533HQ (as filed) Mountain View, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified altoneuroscience.com↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.